Acinetobacter baumannii: Emergence of a Successful Pathogen

AY Peleg, H Seifert, DL Paterson - Clinical microbiology reviews, 2008 - Am Soc Microbiol
Acinetobacter baumannii has emerged as a highly troublesome pathogen for many
institutions globally. As a consequence of its immense ability to acquire or upregulate …

[HTML][HTML] Acinetobacter baumannii: evolution of antimicrobial resistance—treatment options

Y Doi, GL Murray, AY Peleg - Seminars in respiratory and …, 2015 - thieme-connect.com
The first decade of the 20th century witnessed a surge in the incidence of infections due to
several highly antimicrobial-resistant bacteria in hospitals worldwide. Acinetobacter …

2009 年中国CHINET 细菌耐药性监测

汪复, 朱德妹, 胡付品, 阮斐怡, 倪语星, 孙景勇… - 中国感染与化疗 …, 2010 - cqvip.com
目的了解国内不同地区14 所医院临床分离菌对常用抗菌药物的耐药性. 方法国内不同地区14
所教学医院(12 所综合性医院, 2 所儿童医院) 临床分离菌采用K—B 法按统一方案进行细菌药物 …

[HTML][HTML] Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli

L Scudeller, E Righi, M Chiamenti, D Bragantini… - International journal of …, 2021 - Elsevier
Background: The superiority of combination therapy for carbapenem-resistant Gram-
negative bacilli (CR-GNB) remains controversial. In vitro models may predict the efficacy of …

Polymyxins revisited

D Landman, C Georgescu, DA Martin… - Clinical microbiology …, 2008 - Am Soc Microbiol
The global emergence of multidrug-resistant gram-negative bacilli has spurred a renewed
interest in polymyxins. Once discarded due to concerns regarding nephrotoxicity and …

[HTML][HTML] Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections

JA Viehman, MH Nguyen, Y Doi - Drugs, 2014 - Springer
Acinetobacter baumannii is a leading cause of healthcare-associated infections worldwide.
Because of various intrinsic and acquired mechanisms of resistance, most β-lactam agents …

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

DE Karageorgopoulos, ME Falagas - The Lancet infectious diseases, 2008 - thelancet.com
Institutional outbreaks caused by Acinetobacter baumannii strains that have acquired
multiple mechanisms of antimicrobial drug resistance constitute a growing public-health …

A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options

AA Elshamy, KM Aboshanab - Future science OA, 2020 - Future Science
Carbapenems are a class of antimicrobial agents reserved for infections caused by
multidrug-resistant microorganisms. The emergence of carbapenem resistance has become …

Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia

H Aydemir, D Akduman, N Piskin, F Comert… - Epidemiology & …, 2013 - cambridge.org
The aim of this study was to compare the responses of colistin treatment alone vs. a
combination of colistin and rifampicin in the treatment of ventilator-associated pneumonia …

[HTML][HTML] Task force on management and prevention of Acinetobacter baumannii infections in the ICU

J Garnacho-Montero, G Dimopoulos, G Poulakou… - Intensive care …, 2015 - Springer
Introduction Acinetobacter baumannii constitutes a dreadful problem in many ICUs
worldwide. The very limited therapeutic options available for these organisms are a matter of …